AUTHOREA
Log in Sign Up Browse Preprints
LOG IN SIGN UP

1014 covid-19 Wiley Open Research Preprints

Related keywords
covid-19 impact factors cytotoxic t lymphocyte pandemics respiratory tract infections control measures virus classification obesity and exercise receptor binding hospital administration hepatitis b virus universal access to health care services respiratory virus mutation/mutation rate raa biostatistics & bioinformatics disease control rabies virus evolution humoral immunity respiratory tract learners’ acceptance rapid detection vaccines/vaccine strains sars-cov-2 antibodies + show more keywords
nutrition hospital pathogenesis paediatrics and adolescent medicine antiviral agents covid 19 genetics acute respiratory infections endocrinology and metabolic disorders respiratory medicine waiting lists serosurvey emergency medicine genetic variability adenovirus sentinel surveillance coronavirus drug specificity ophthalmology bronchiolitis immune responses seroprevalence t cell covid-19-related death genetic variation epidemiology course specification cohort design respiratory pathogens sars-cov-2 e-assessment influenza immnopathology immune system infection b cell infectious diseases isothermal amplification unity studies allergy covid-19 pandemic sars coronavirus healthcare management combination therapy vaccine effectiveness bamako hospitalisation surgery department cameroon mali immunity/immunization
FOLLOW
  • Email alerts
  • RSS feed
Please note: These are preprints and have not been peer reviewed. Data may be preliminary. Preprints should not be relied on to guide medical practice or health-related decisions. News media reporting on preprints should stress that the research should not yet be considered conclusive.
Pediatric Systemic Lupus Erythematosus (SLE) after COVID-19 vaccination: A case repor...
Rafat Noeiaghdam
Shabnam  Hajiani

Rafat Noeiaghdam

and 3 more

June 05, 2023
A document by Rafat Noeiaghdam. Click on the document to view its contents.
TRACKING SARS-COV-2 TRANSMISSION AND CO-INFECTION WITH OTHER ACUTE RESPIRATORY PATHOG...
Vincent Ruttoh
Samwel   Symekher

Vincent Ruttoh

and 13 more

May 30, 2023
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has been the most significant public health challenge in over a century. SARS-COV-2 has infected over 765 million people worldwide, resulting in over 6.9 million deaths. This study aimed to detect community transmission of SARS-CoV-2 and monitor the co-circulation of SARS-CoV-2 with other acute respiratory pathogens in Rift Valley, Kenya. We conducted a cross-sectional active sentinel surveillance for the SARS-CoV-2 virus among patients with acute respiratory infections at four sites in Rift Valley from January 2022 to December 2022. 1271 patients of all ages presenting with influenza-like illness were recruited into the study. Nasopharyngeal swab specimens were screened using a multiplex RT–qPCR for SARS-CoV-2, Influenza A, Influenza B and RSV. Influenza A and RSV samples were subtyped, and all the SARS-CoV-2 positive samples were further screened for 12 viral and 7 bacterial respiratory pathogens. We had a prevalence of 13.93% SARS-CoV-2, Influenza A 5.7%, Influenza B 1.96% and 0.94%. Influenza A-H1pdm09 and RSV B were the most dominant circulating subtypes of Influenza A and RSV, respectively. The most common co-infecting pathogens were Streptococcus pneumoniae and Haemophilus influenzae, accounting for 16.4% and 10.7% of all the SARS-CoV-2 positive samples. Augmenting syndromic testing in ARI surveillance is crucial to inform evidence-based clinical and public health interventions.
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death...
Irina Kislaya
Alexis Sentís

Irina Kislaya

and 19 more

May 29, 2023
Background: Within the ECDC-VEBIS project, we prospectively monitored vaccine effectiveness (VE) against COVID-19 hospitalisation and COVID-19-related death, using electronic health registries (EHR), between October 2021 and November 2022, in community-dwelling residents aged 65–79 and ≥80-years in six European countries. Methods: EHR linkage was used to construct population cohorts in Belgium, Denmark, Luxembourg, Navarre (Spain), Norway and Portugal. Using a common protocol, for each outcome (hospitalisation and death), VE was estimated monthly over eight-week follow-up periods, allowing one month-lag for data consolidation. Cox proportional-hazards regression models were used to estimate adjusted hazard ratios (aHR) and VE=(1 – aHR) x100. Site-specific estimates were pooled using random-effects meta-analysis. Results: For ≥80-years, VE against COVID-19 hospitalisation decreased from 66.9% (95%CI: 60.1; 72.6) to 36.1% (95%CI: -27.3; 67.9) for the primary vaccination and from 95.6% (95%CI: 88.0; 98.4) to 67.7% (95%CI: 45.9; 80.8) for the first booster. Similar trends were observed for 65-79-years. The second booster VE against hospitalisation ranged between 82.0% (95%CI: 75.9; 87.0) and 83.9% (95%CI: 77.7; 88.4) for the ≥80-years and between 39.3% (95%CI: -3.9; 64.5) and 80.6% (95%CI: 67.2; 88.5) for 65-79-years. The first booster VE against COVID-19-related death declined over time for both age groups, while the second booster VE against death remained above 80% for the ≥80-years. Conclusions: Successive vaccine boosters played a relevant role in maintaining protection against COVID-19 hospitalisation and death, in the context of decreasing VE over time. Multi-country data from EHR facilitate robust near-real-time monitoring of VE in the EU/EEA and supports public health decision-making.
Surgical waiting lists and queue management in a Brazilian tertiary public hospital
Antonio Pazin-Filho
Maria Eulália Lessa do Valle Dallora

Antonio Pazin-Filho

and 10 more

May 24, 2023
Introduction: Centralized management of queues helps to reduce the surgical waiting time in the publicly funded healthcare system, but this is not a reality in the Brazilian Unified Healthcare System. Objectives: To describe the implementation of the “Patients with Surgical Indication” (PSI) in a Brazilian public tertiary hospital; To assess the impact on waiting time and its use in rationing oncological surgeries during the COVID-19 Pandemic. Methods: Retrospective observational study of elective surgical requests (2016-2022) in a Brazilian general, public, tertiary university hospital. We recovered information regarding the inflows (indications), outflows and their reasons, the number of patients, and waiting time in queue. Results: We enrolled 82,844 indications in the PSI (2016-2022). The waiting time (median and interquartile range) in days decreased from 98(48;168) in 2016 to 14(3;152) in 2022 (p<0.01). The same occurred with the backlog that ranged from 6,884 in 2016 to 844 in 2022 (p<001). During the Pandemic, there was a reduction in the number of non-oncological surgeries per month (95% confidence interval) of -10.9(-18.0;-3.8) during Phase I (January 2019-March 2020), maintenance in Phase II (April 2020-August 2021) 0.1(-10.0;10.4) and increment in Phase III (September 2021-December 2022) of 23.0(15.3;30.8). In the oncological conditions, these numbers were 0.6(-2.1;3.3) for Phase I, an increase of 3.2(0.7;5.6) in Phase II and 3.9(1 ,4;6,4) in Phase III. Conclusion: Implementing a centralized list of surgical indications and developing queue management principles proved feasible, with effective rationing. It unprecedentedly demonstrated the decrease in the median waiting time in Brazil.
Association of the traditional Chinese medicine treatment intensity and negative conv...
Shunxian Zhang
Yu Tian

Shunxian Zhang

and 13 more

May 19, 2023
The association between traditional Chinese medicine (TCM) treatment intensity (TI) and the clinical therapeutic outcomes of patients with mild to moderate COVID-19 symptoms has not been fully understood. A retrospective cohort study was undertaken to assess the therapeutic effect of traditional Chinese medicine (TCM) on patients with mild COVID-19. Between April and May 2022, a total of 6,120 confirmed COVID-19 cases were enrolled from temporary hospitals in Shanghai City. Patients receiving TCM treatment were identified through their daily prescriptions. The nonlinearity and cutoff point of this relationship were determined using a restricted cubic spline model. The study included 6,120 mild COVID-19 cases with a median (range) age of 43.0 (2.0, 75.0) years,a median (range) hospitalization duration of 9.7 (4.1, 22.5) days, a median (range) of taking TCM of 2.0 (0.0, 15.0) days, and the median (range) negative conversion time of SARS-CoV-2 nucleic acid was 6.67 (95% confidence interval [ CI]: 4.1, 22.5) days, with 1854 women (30.3%) among the participants. The restricted cubic spline model revealed significant nonlinear association between TCMTI and the negative nucleic acid conversion time, and the statistical test results of all three parameters were statistically significant. The cutoff value of TCMTI is 0.65. The high TCMTI group showed a significant reduction in the median negative conversion time of SARS-CoV-2 nucleic acid (hazard ratio [ HR]=1.769 [95% CI: 1.575, 1.986]) and a decrease in hospitalization duration (coefficient=-0.146, P<0.001) compared with the low TCMTI group after adjustment for confounding variables. The restricted mean negative conversion time of SARS-CoV-2 nucleic acid of high TCMTI group was 1.909 (1.675, 2.144) days shorter than that of the low TCMTI group ( P<0.001). These findings could be utilized to recommend the use of TCM to treat mild COVID-19 patients and prevent overburdening of medical facilities. Trial Registration: The trial was prospectively registered on Chinese Clinical Trial Registry (ChiCTR, ChiCTR2200063151, [http://www.chictr.org.cn/](http://www.chictr.org.cn/) ).
Efficacy and Safety of Oral Pentoxifylline in the Treatment and Recovery of Patients...
Farnoosh Seirafianpour
Simin Almasi

Farnoosh Seirafianpour

and 11 more

May 18, 2023
Backgrounds: The absence of a gold-standard treatment for COVID-19 infection encourages clinicians to benefit from multipotential medications in the treatment of COVID-19. The current controlled randomized clinical trial tried to evaluate the efficacy and safety of pentoxifylline (PTX) as an adjuvant therapy in moderate to severe COVID-19 infection. Methods: In this randomized controlled clinical trial, two groups of hospitalized patients with moderate to severe COVID-19 infection were randomized by the block randomization method to either receive standard protocol therapy or standard protocol therapy plus pentoxifylline 400 mg TDS for 14 days. Results: The results showed a greater improvement in the proinflammatory biomarkers in the intervention group. Oxygen saturation, hemoglobin, and platelet levels were also improved to a higher level among pentoxifylline recipients. The mortality rate was reported 4% and 32% in the intervention and control groups, respectively. One out 13 patients with severe COVID-19 infection expired in the intervention group, while 20 out of 28 patients expired in the control group, showing about 10 times higher mortality rate compared to the pentoxifylline recipients. Conclusion: Pentoxifylline increased the survival rate of COVID-19 patients and played as a preventive role for COVID-related mortality and morbidity such as acute respiratory distress syndrome.
Clinical Performance of the STANDARD M10 SARS-CoV-2 Rapid RT-PCR Assay in an Emergenc...
Mi Hyun Bae
Dong-hyun Lee

Mi Hyun Bae

and 5 more

May 17, 2023
Background: In emergency departments, rapid screening of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is important for arranging limited isolation resources and patient care during the coronavirus disease 2019 (COVID-19) pandemic. STANDARD M10 SARS-CoV-2 (SD Biosensor) is a recently developed cartridge-based RT-PCR that provides a turnaround time of 1 h, which is shorter than that for conventional RT-PCR. This study evaluated the clinical performance of STANDARD M10 in an emergency department. Methods: From March to June 2022, two pairs of nasopharyngeal and oropharyngeal swabs were collected from patients visiting an emergency department. Respective specimens underwent rapid RT-PCR using STANDARD M10 and conventional RT-PCR using Allplex SARS-CoV-2 (Seegene). When discordant results occurred, specimens undergoing the STANDARD M10 were retested with the Allplex to exclude specimen variations. Retest results replaced initial results of the Allplex. Clinical performance of STANDARD M10 was compared with Allplex. Results: The study enrolled 1,971 patients. COVID-19 prevalence was 6.2% based on the Allplex. Compared with the Allplex, overall agreement, positive percent agreement, and negative percent agreement of STANDARD M10 were 99.5% (95% CI: 99.1–99.8%), 95.9% (95% CI: 90.8–98.3%), and 99.8% (95% CI: 99.4–99.9%), respectively. Discordant results between STANDARD M10 and Allplex were observed only in specimens with Ct >33 using the Allplex. Conclusions: The STANDARD M10 showed reliable diagnostic performance for detecting SARS-CoV-2 in emergency departments and is a useful tool in emergency healthcare systems because of its easy-to-use cartridge-based assay and short resulting time for detecting SARS-CoV-2.
Fluorescent reverse transcription recombinase-aided amplification assay for sensitive...
Xudong Guo
Dongli Gao

Xudong Guo

and 8 more

May 17, 2023
Background: Rapid detection of pathogens is important for the timely control of outbreaks, especially for respiratory infectious diseases that are prone to spread and outbreaks. Methods: In this work, we developed a sensitive reverse transcription recombinase-aided amplification (RT-RAA) assay for the rapid detection of six common respiratory viruses including respiratory syncytial virus type A (RSVA), influenza A virus (Flu A), influenza B virus (Flu B), human parainfluenza virus (HPIV), SARS-CoV-2 and adenovirus (ADV). The nucleic acid standards and pharyngeal swab samples were used to test the sensitivity, specificity, reliability of the established RAA assay. Results: The assay could be completed within 20 minutes at 39℃ using a portable built-in power device. The detection limits for the six viruses were all less than 1000 copies/mL and reached 10 copies/mL for ADV. Excellent specificity was demonstrated by cross-testing with 21 different pathogen nucleic acids. The results of RT-RAA and RT-PCR were consistent in 85 laboratory-conserved pharyngeal swab samples, but RT-RAA was more time-saving and portable. Meanwhile, the RT-RAA assay using the same test procedure for six viruses could allow operators the flexibility to select the number of samples and pathogens to be detected in one test. Conclusions: This portable, sensitive and reliable RT-RAA assay for rapid detection of multiple respiratory viruses could be applied to health resource-poor areas and outbreak sites.
Neuroimmunology of rabies: new insights into an ancient disease
Otavio Cabral-Marques
Victor Bastos

Otavio Cabral-Marques

and 18 more

May 16, 2023
Rabies is an ancient neuroinvasive viral (genus Lyssavirus, family Rhabdoviridae) disease affecting approximately 59,000 people worldwide. The central nervous system (CNS) is targeted, and rabies has a case fatality rate of almost 100% in humans and animals. Rabies is entirely preventable through proper vaccination, and thus, the highest incidence is typically observed in developing countries, mainly in Africa and Asia. However, there are still cases in European countries and the US. Recently, demographic, increasing income levels, and the coronavirus disease 2019 (COVID-19) pandemic have caused a massive raising in the animal population, enhancing the need for preventive measures (e.g., vaccination, surveillance, animal control programs), post-exposure prophylaxis, and a better understanding of rabies pathophysiology to identify therapeutic targets, since there is no effective treatment after the onset of clinical manifestations. Here we review the neuroimmune biology and mechanisms of rabies. Its pathogenesis involves a complex and poorly understood modulation of immune and brain functions associated with metabolic, synaptic, and neuronal impairments, resulting in fatal outcomes without significant histopathological lesions in the CNS. In this context, the neuroimmunological and neurochemical aspects of excitatory/inhibitory signaling (e.g., GABA/glutamate crosstalk) are likely related to the clinical manifestations of rabies infection. Uncovering new links between immunopathological mechanisms and neurochemical imbalance will be essential to identify novel potential therapeutic targets to reduce rabies morbidity and mortality.
Memory T-cell targeted immune response in patients of liver cirrhosis and immunocompe...
Geeta Yadav
Dandu Reddy

Geeta Yadav

and 9 more

May 16, 2023
Despite the effectiveness of COVID-19 vaccination in reducing the severity of the disease, the demand for booster is increasing in vulnerable populations like elderly and immunocompromised individuals especially with each new wave of COVID-19 in different countries. There is limited data on the sustained immunity against COVID-19 in patients with liver cirrhosis. The study was aimed to compare the T-cell and humoral immune response after one year of ChAdOx1nCoV-19 Vaccine in patients with liver cirrhosis and healthy health-care workers (HCW). This was a prospective observational study including 36 HCW,19 liver cirrhosis patients and 10 unvaccinated individuals. Anti-SARS-CoV-2S antibody, neutralizing antibody and memory T-cell subsets were evaluated by ELISA and flow cytometry respectively in all three groups after one year of initial vaccination. Compared to HCW and unvaccinated individuals, liver cirrhosis patients had significantly depleted T-cells, although CD4:CD8+ T-cell ratio was normal. Significant difference was noted in various memory subsets [effector memory RA (P= 0.141, P= 0.000), effector memory (P= 0.000, P= 0.00), central memory (P= 0.000, P= 0.00), stem cell memory (P= 0.009, P= 0.08) and naïve (P= 0.000, P= 0.02)] of CD4+T and CD8+T respectively. However, on post-hoc analysis no difference was noted in the extent of memory T-cells between cirrhotic patients and HCW. Patients with liver cirrhosis developed comparable memory T-cells after vaccination which can evoke sustainable immune response on reinfection. Therefore, additional vaccine doses may not be necessary for cirrhosis patients.
Waiting for the next winter. Outpatient pediatric visits for respiratory infections b...
Fernando Ferrero
Paula Gonzalez Pannia

Fernando Ferrero

and 3 more

May 12, 2023
Introduction: During the COVID-19 pandemic, pediatric visits due to acute lower respiratory infections (ALRIs) decreased, but most reports are from hospitalized patients. There is little information on this phenomenon in outpatients, who are the majority in IRABs. We evaluated the impact of the COVID-19 pandemic on ALRIs related outpatient visits in the City of Buenos Aires. Methods: Observational study including all outpatient visits of children under 2 years of age to the public health system of the City of Buenos Aires, between Jan 01, 2018 and Dec 31, 2022. We estimated the total number visits and the ALRIs-related visits, and their distribution throughout the study period. Results: A total of 704,426 visits were registered, 7.38% of them due to ALRIs. ALRIs-related visits decreased from the implementation of a national lockdown (2020) and increased again as the restriction measures decreased, particularly the return to full school attendance (2021). In general, the proportion of ALRIs-related vists was significantly higher in the cold months than in the warm ones (9.8% vs. 5.5%; OR: 1.76, 95%CI: 1.73-1.79; p<0.001). This difference was observed before (2018, 2019) and after the pandemic (2022), but not in 2020-2021. The peak of ALRIs-related visits occurred in the cold months in pre-pandemic years (2018-2019), did not appear in 2020, reappeared delayed in 2021 and recovered seasonality in 2022. Conclusion: Outpatient ALRIs-related visits decreased significantly in the city of Buenos Aires during the COVID-19 pandemic and currently seem to have recovered their magnitude and seasonality.
Relationship between Newcastle virus interference phenomenon and treatment of covid-1...
Masoud Moghaddam Pour

Masoud Moghaddam Pour

May 12, 2023
I was infected with the Covid-19 virus .On the seventh day after sickness , 0.1 ml (log 108 /ml) of live Newcastle (strain I 2 ) vaccine was inoculated through nasal drops .After about 12 hours, unbelievably all the symptoms of Covid-19 were disappeared .
RESPIRATORY PATHOGENS CIRCULATION AMONG NON-REACTIVE SARS-CoV2 PATIENTS DURING THE CO...
ZAKIA REGRAGUI
ABDERRAHMAN BIMOUHEN

ZAKIA REGRAGUI

and 12 more

May 11, 2023
Background: The outbreak of SARS-COV-2 has necessitated the implementation of urgent measures to suppress the transmission of the virus, including the mandatory public use of masks, regular hand washing, and social distancing. These measures may also be effective in reducing other respiratory infectious deseases, such as Influenza and severe acute respiratory illness. Therefore, the aim of the study was to estimate the prevalence of respiratory pathogens among SARS-CoV2 non-reactive patients, admitted in healthcare facilities in the context of COVID-19 management. Material and Method: From February to July 2021, a total number of 167 nasopharyngeal swabs from adults fitting the case definition of COVID-19 syndrome and negative to SARS-CoV-2 were enrolled from seven regional sites in Morocco.All samples were subject to a multiplexed nucleic acid test intended for the simultaneous detection and differentiation of 22 respiratory pathogens. Results: Our study showed that overall, theprevalence of respiratory pathogens was 43% (n=72). The main detected pathogens were typed as Human Rhinovirus (HRV) (38%), Human Coronavirus OC43 (37%) and Human Parainfluenza3 (HPIV3) (12%). Conclusion: Our findings support the notion that during the SARS-CoV2 pandemic, the detection of Influenza A/B, Human Metapneumovirus, and Respiratory Syncytial Virus all declined. Meanwhile, there was a noticeable increase in HRV and HCoV OC43. The dynamics of airborne transmission and epidemic patterns were thus assumed to be greatly improved by the SARS-CoV-2 prophylactic measures. These findings could be useful in guiding future prevention and management of respiratory illnesses.
Sequence analysis of the Spike, nsp12 (RNA-dependent RNA polymerase), nsp3 (PLpro), a...
Mohamad Hakim
* Gunadi

Mohamad Hakim

and 19 more

May 10, 2023
During the Covid-19 pandemic, the resurgence of SARS-CoV-2 was due to the development of novel variants of concern (VOC). Thus, genomic surveillance is essential to monitor continuing evolution of SARS-CoV-2 and to track the emergence of novel variants. In this study, we performed phylogenetic, mutation, and selection pressure analyses of the Spike, nsp12, nsp3, and nsp5 genes of SARS-CoV-2 isolates circulating in Yogyakarta and Central Java provinces, Indonesia from May 2021 to February 2022. Various bioinformatics tools were employed to investigate the evolutionary dynamics of distinct SARS-CoV-2 isolates. During the study period, 213 and 139 isolates of Omicron and Delta variants were identified, respectively. Particularly in the Spike gene, mutations were significantly more abundant in Omicron than in Delta variants. Consistently, in all of four genes studied, the substitution rates of Omicron were higher than that of Delta variants, especially in the Spike and nsp12 genes. In addition, selective pressure analysis revealed several sites that were positively selected in particular genes, implying that these sites were functionally essential for virus evolution. In conclusion, our study demonstrated a distinct evolutionary pattern of SARS-CoV-2 variants circulating in Yogyakarta and Central Java provinces, Indonesia.
Seroprevalence of SARS-CoV-2 antibodies in the general population of Bamako, Mali, an...
Bourama  Traoré
Merepen  Guindo

Bourama Traoré

and 25 more

May 10, 2023
Background: The seroepidemiological characteristics of SARS-CoV-2 infection in Mali are not yet well understood. This study assessed SARS-CoV-2 antibody seroprevalence and factors associated with infection in the general population of Bamako, the capital city and epicenter of COVID-19, to determine the magnitude of the pandemic and contribute to control strategies improvement in Mali. Methods: A cross-sectional survey was conducted in September 2022 to collect data on sociodemographic information, clinical characteristics, comorbid factors, and blood samples. ELISA was performed to determine anti-Spike (S) and anti-RBD antibody levels, and RT-PCR to confirm SARS-CoV-2 infection in oropharyngeal swabs. A total of 3601 participants were enrolled in RedCap. Result: the mean age of participants was 33.5±15.9 years old; the sex ratio female: male was 3.6:1. The most representative were the 20–29 (28.9%, n=1043) and the 30–39 (26.9%, n=967) years-old. The COVID-19 vaccine coverage among the participants was 35.8%, with vaccines from Covidshield AstraZeneca (AZ, 13.4%), Johnson and Johnson (J&J, 16.7%), Sinovac (3.9%), and BioNTech Pfizer (1.8%). Overall, S protein and RBD antibodies seroprevalence was remarkably high in the general population (98% and 97%, respectively). Factors such as youth (1–9 years old) and male sex were associated with lower antibody responses against S and RBD, whereas previous exposure to patients with COVID-19 and receiving the COVID-19 vaccine were associated with increased odds of antibody responses. Conclusion: This serosurvey demonstrated the high seroprevalence of SARS-CoV-2 antibodies and highlighted the factors that may influence antibody responses, clearly underlining an underestimation of the pandemic in Mali.
Molecular PET/CT mapping of rhACE2 distribution and quantification in organs to aid i...
Hua Zhu
Zilei Wang

Hua Zhu

and 11 more

May 08, 2023
Objectives The aim of this study was to assess the potential of noninvasive and repeated monitoring of rhACE2 distribution and content in organs using the ACE2-specific nuclide probe 68Ga-HZ20. Methods We optimized the labeling conditions of the probe and evaluated its safety. A mouse organ in situ rhACE2 high-aggregation model was constructed for the first time, and in vivo real-time PET imaging of rhACE2 was performed using the ACE2-specific PET agent 68Ga-HZ20. The distribution and uptake of the probe were analyzed, and the model was validated. Results This radiotracer exhibited reliable radiochemical properties in vitro and maintained a high affinity for rhACE2 in vivo. In terms of probe uptake, 68Ga-HZ20 showed a good target-to-nontarget ratio, and the correlation between the uptake value of the probe and the dose of rhACE2 was >90% in both models; the probe was rapidly cleared from the circulatory system and excreted by the kidneys and urinary system. No organs were damaged after the injection of high doses of probe. Conclusions This technology for noninvasively and repeatedly monitoring the content and distribution of rhACE2 in vivo aids in clarifying the resident capacity of rhACE2 in organs and in analyzing the preventive effect of rhACE2 against SARS-CoV-2 and the effectiveness of therapies for COVID-19.
Seroprevalence of SARS-CoV-2 in 10 Regional Capitals of Cameroon, October-December 20...
Karampreet Sachathep
Tiffany Harris

Karampreet Sachathep

and 22 more

May 04, 2023
Cameroon was among the most affected African countries during the first wave of the COVID-19 pandemic; however, the true prevalence of SARS-CoV-2 remains unknown. From October-December 2020 we conducted a cross-sectional, age-stratified SARS-CoV-2 seroepidemiological survey at 30 purposively selected community-based sites across Cameroon’s 10 regional capitals, sampling 10,000 individuals aged 5 years or older. We employed a parallel SARS-CoV-2 antibody testing algorithm (WANTAI ELISA and Abbot Architect) to improve both the positive predictive value and negative predictive value of seroprevalence. The overall weighted and adjusted seroprevalence of SARS-CoV-2 antibodies across the 10 urban capitals of Cameroon was 10.5% (95% CI: 9.1%-12.0%) among participants aged ≥5 years. Of the 9332 participants, 730 males (13.1%, 95% CI: 11.5%-14.9%) had SARS-CoV-2 antibodies compared to 293 females (8.0%, 95% CI: 6.8%—9.3%). Among those who reported a comorbidity at the time of testing, 15.8% (95% CI: 12.8%-19.4%) were seropositive. We estimated that over 2 million SARS-CoV-2 infections occurred in the 10 regional capitals of Cameroon between October and December 2020, compared to 21,160 cases officially reported at that time translating to one laboratory-confirmed case was reported for every 110 SARS-CoV-2 infections across the 10 urban capitals. This study’s findings point to extensive and under-reported circulation of SARS-CoV-2 in Cameroon– an almost 100-fold more cases compared to the number of cases reported to the World Health Organization. This finding highlights the importance of conducting serosurveys, especially in settings where access to testing may be limited and to repeat such surveys as part of pandemic tracking.
A Rare Case of Osteomalacia with Proximal Myopathy persisting despite Vitamin D suppl...
Mohammad  Hazique
Arihant Surana

Mohammad Hazique

and 5 more

May 04, 2023
A document by Mohammad Hazique . Click on the document to view its contents.
Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T cell respo...
Willem A. Mak
Wendy Visser

Willem A. Mak

and 5 more

May 02, 2023
COVID-19 bivalent ancestral/Omicron mRNA booster vaccinations became available to boost and expand the immunity against SARS-CoV-2 Omicron infections. In a prospective cohort study including 59 healthcare workers, we assessed SARS-CoV-2 ancestral and Omicron BA.5-specific neutralizing antibody and T cell responses in previously infected and infection-naive individuals. Also, we assessed the effect of an ancestral/Omicron BA.1 bivalent mRNA booster vaccination on these immune responses. 10 months after previous monovalent mRNA vaccinations, ancestral SARS-CoV-2 S1-specific T cell and anti-RBD IgG responses remained detectable in most individuals and a previous SARS-CoV-2 infection was associated with increased T cell responses. T cell responses, anti-RBD IgG, and Omicron BA.5 neutralization activity increased after receiving an ancestral/Omicron BA.1 bivalent booster mRNA vaccination. An Omicron BA.5 infection in addition to bivalent vaccination led to a higher ratio of Omicron BA.5 to ancestral strain neutralization activity compared to bivalent vaccination without a recent SARS-CoV-2 infection. In conclusion, SARS-CoV-2 T cell and antibody responses persist for up to 10 months after a monovalent booster mRNA vaccination. An ancestral/Omicron BA.1 bivalent booster mRNA vaccination increases these immune responses and also induces Omicron BA.5 cross-neutralization antibody activity. Finally, our data indicate that hybrid immunity is associated with improved preservation of T cell immunity.
Short Communication - Lessons learnt during the implementation of Unity-aligned SARS-...
Elise Farley
Joseph  Okeibunor

Elise Farley

and 14 more

May 02, 2023
The WHO Unity Studies initiative engaged low- and middle-income countries in the implementation of standardized SARS-CoV-2 sero-epidemiological investigation protocols and timely sharing of comparable results for evidence-based action. To gain a deeper understanding of the methodological challenges faced when conducting seroprevalence studies in the Africa region, we conducted unstructured interviews with key study teams in five countries. We discuss the challenges identified: participant recruitment and retention, sample frame, sample and data management, data analysis and presentation to policy makers. Potential solutions to aid future implementation include preparedness actions such as the development of new tools, robust planning and practice.
Comparison of Semen Parameters in the Same Patients Before and After Diagnosis of COV...
C. Cakir
G. Kuspinar

C. Cakir

and 7 more

April 29, 2023
Clinical and histopathological evidence suggest that the male reproductive system may be negatively impacted in patients with coronavirus disease (COVID-19). The objective of this study is to investigate the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on semen parameters by comparing semen analyses before and after COVID-19 diagnosis in the same patient. We retrospectively analyzed 342 semen analyses by reviewing medical records. The study included two groups of patients: (i) those who underwent two consecutive semen analyses within 6 months, one before (n=114) and one after (n=114) COVID-19 diagnosis, and (ii) a control group (n=114) that was age-matched and did not receive a diagnosis of COVID-19. The study results indicated a significant decrease in semen volume, total sperm count per ejaculate, progressive motile sperm count, total motile sperm count, and normal sperm morphology after SARS-CoV-2 infection in comparison to their respective values before the infection. Subgroup analyses showed that the duration of COVID-19 diagnosis (short-term vs long-term) did not impact the changes in semen parameters. However, fever during the COVID-19 process had a negative effect on semen parameters, particularly sperm concentration, unlike in patients without fever. In conclusion, our findings suggest that SARS-CoV-2 infection is associated with a decline in semen quality, which may potentially impact male fertility. Furthermore, it’s important to note that the negative effects on semen parameters may persist in the long-term. Our results also indicate that fever during active infection could be a significant risk factor that negatively affects spermatogenesis.
E-Assessment During COVID-19 Pandemic at a Saudi university: Impact on Assessment Met...
Abdullah Al Mamun Bhuiyan
A. K. M. Mazharul Islam

Abdullah Al Mamun Bhuiyan

and 1 more

April 27, 2023
The deployment of e-assessments has been so frequent in educational institutions worldwide during the COVID-19 pandemic. It is worth questioning the efficacy of this newly adopted evaluation method. The study aims to determine how far this testing effectively achieves the Course Learning Outcomes. It also tries to explore the extent of difference between the online assessment method from the pre-pandemic testing methods stated in the course specification. Another aim of the study is to check the acceptance of e-tests by the learners. This study employs a quantitative approach encompassing a Likert-type online questionnaire to gather the response of 70 faculty members at XXXX in Saudi Arabia. The primary result of this study is that e-assessment succeeds in attaining Course Learning Outcomes to a great extent. Though these newly adopted tests shifted away from the stated measurement methods in the course specification, the learners accepted them enthusiastically. It was discovered in the study that if educational institutes have well-structured e-learning infrastructures and regularly use these setups competently, they confront minor complexities to switching to online ones and achieve Course Learning Outcomes applying e-assessment systems.
Bilateral acute anterior uveitis and optic nerve edema as a manifestation of coronavi...
Aria Mohamadzadeh
Dena Mohamadzadeh

Aria Mohamadzadeh

and 1 more

April 26, 2023
Introduction: Coronavirus disease-2019 (COVID-19) is a novel infection, that first appeared in Wuhan, China. It has been well established that different organs including the heart, kidney, pulmonary and gastrointestinal systems might be involved during or post COVID-19 infection. A possible reason is that the virus enters host cells through the angiotensin-converting enzyme 2 (ACE 2) receptor and this receptor is expressed by different human organs [1]. ACE 2 receptor is also expressed in different parts of the eyes including the conjunctiva, cornea, limbus, aqueous humor, and retina [2].In addition, COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) can affect different organ systems including skin, renal, cardiac, hematological, and gastrointestinal systems. But ocular involvement is not still a part of the world health organization (WHO) criteria or the Center for Disease Control and Prevention criteria for MIS-C [3].Whether uveitis or optic disk edema would be manifestations of acute COVID-19 infection or they can occur as a part of COVID-19-associated MIS-C is still unknown.
Molecular epidemiology of Human Adenovirus in Asturias (2011–2023)
Santiago melon
Marta Alvarez-Arguelles

Santiago melon

and 8 more

April 26, 2023
Human Adenoviruses (HAdV) are implicated in multiples pathologies causing mild to severe disease. The predominant genotypes detected in association with disease differ among different countries or regions, and change over time. In Spain and elsewhere little is known about the molecular epidemiology of HAdV. From a total of 250 HAdV, members of five species were present: A (1), B (126), C (87), D (27) and E (9). The most found genotypes were B3 (119), C2 (48), C1 (29) and D8 (26). Genotypes E4, C5, C6, B7, A31, B35 and D56 were also detected. HAdV diversity increases over the years until the B3 genotype displaces all other types in 2016 and 2023. HAdV detected in Asturias were similar to those already described in other countries, no new local genotype were observed. Genotypes 1-7 were more frequent in children under 15 years of age, while types 8-56 were more frequent in the elderly. Multiple HAdV introductions must have occurred given that only small transmission clades can be inferred. The diversity of the epidemic increased with the years until it disappeared one year periodically .The COVID-19 epidemic accelerated the loss of diversity suggesting that interventions during the pandemic were able to reduce HAdV transmission.
← Previous 1 2 3 4 5 6 7 8 9 … 42 43 Next →
Back to search
Wiley Open Research

| Powered by Authorea.com

  • Home